Novel motif:145
From FANTOM5_SSTAR
name: | motif145_GMAGWCGMAW |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0045650 | negative regulation of macrophage differentiation | 1.439800e-13 |
GO:0045649 | regulation of macrophage differentiation | 4.990777e-13 |
GO:0090304 | nucleic acid metabolic process | 1.060679e-10 |
GO:0044260 | cellular macromolecule metabolic process | 1.207293e-9 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.557040e-9 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.621969e-9 |
GO:0010467 | gene expression | 3.316747e-9 |
GO:0009059 | macromolecule biosynthetic process | 3.782931e-9 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 4.050155e-9 |
GO:0019230 | proprioception | 1.039052e-8 |
GO:0071248 | cellular response to metal ion | 1.307857e-8 |
GO:0001893 | maternal placenta development | 1.572071e-8 |
GO:0035845 | photoreceptor cell outer segment organization | 2.045224e-8 |
GO:0071281 | cellular response to iron ion | 3.324059e-8 |
GO:0006413 | translational initiation | 4.208726e-8 |
GO:0046548 | retinal rod cell development | 4.451355e-8 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.712232e-8 |
GO:0016070 | RNA metabolic process | 5.923588e-8 |
GO:0043170 | macromolecule metabolic process | 6.229991e-8 |
GO:0071277 | cellular response to calcium ion | 2.332570e-7 |
GO:0035458 | cellular response to interferon-beta | 2.342971e-7 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 4.692457e-7 |
GO:0009107 | lipoate biosynthetic process | 7.090703e-7 |
GO:0034389 | lipid particle organization | 9.272866e-7 |
GO:0051355 | proprioception involved in equilibrioception | 9.503430e-7 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.012516e-6 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.202887e-6 |
GO:0016339 | calcium-dependent cell-cell adhesion | 1.707060e-6 |
GO:0006807 | nitrogen compound metabolic process | 2.262653e-6 |
GO:0044237 | cellular metabolic process | 2.508743e-6 |
GO:0072657 | protein localization in membrane | 2.769469e-6 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 2.824690e-6 |
GO:0032042 | mitochondrial DNA metabolic process | 3.152426e-6 |
GO:0032908 | regulation of transforming growth factor beta1 production | 3.162198e-6 |
GO:0002688 | regulation of leukocyte chemotaxis | 3.358693e-6 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 3.485276e-6 |
GO:0010966 | regulation of phosphate transport | 3.511482e-6 |
GO:0009266 | response to temperature stimulus | 3.607957e-6 |
GO:0032774 | RNA biosynthetic process | 3.671748e-6 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 3.923609e-6 |
GO:0035928 | rRNA import into mitochondrion | 3.997885e-6 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 4.683551e-6 |
GO:0050902 | leukocyte adhesive activation | 4.683551e-6 |
GO:0010890 | positive regulation of sequestering of triglyceride | 4.785983e-6 |
GO:0071241 | cellular response to inorganic substance | 5.461422e-6 |
GO:0045792 | negative regulation of cell size | 5.783433e-6 |
GO:0031334 | positive regulation of protein complex assembly | 5.937551e-6 |
GO:0021623 | oculomotor nerve formation | 6.688145e-6 |
GO:0003409 | optic cup structural organization | 6.688145e-6 |
GO:0003404 | optic vesicle morphogenesis | 6.688145e-6 |
GO:0071634 | regulation of transforming growth factor beta production | 7.275934e-6 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 7.547776e-6 |
GO:0048266 | behavioral response to pain | 8.666519e-6 |
GO:0000226 | microtubule cytoskeleton organization | 8.896469e-6 |
GO:0045766 | positive regulation of angiogenesis | 8.969262e-6 |
GO:0032570 | response to progesterone stimulus | 9.143512e-6 |
GO:0032006 | regulation of TOR signaling cascade | 9.465392e-6 |
GO:0048333 | mesodermal cell differentiation | 9.595990e-6 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 9.631457e-6 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 9.631457e-6 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 9.631457e-6 |
GO:0009987 | cellular process | 9.850994e-6 |
GO:0006467 | protein thiol-disulfide exchange | 1.011142e-5 |
GO:0071675 | regulation of mononuclear cell migration | 1.093396e-5 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 1.211479e-5 |
GO:0006412 | translation | 1.656735e-5 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 1.709848e-5 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.720890e-5 |
GO:0008152 | metabolic process | 1.727571e-5 |
GO:0051029 | rRNA transport | 1.728549e-5 |
GO:0000002 | mitochondrial genome maintenance | 1.797267e-5 |
GO:0006351 | transcription, DNA-dependent | 1.804219e-5 |
GO:0030431 | sleep | 1.819015e-5 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 1.822587e-5 |
GO:0010758 | regulation of macrophage chemotaxis | 1.949278e-5 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.950442e-5 |
GO:0009408 | response to heat | 1.987416e-5 |
GO:0071800 | podosome assembly | 2.143925e-5 |
GO:0010842 | retina layer formation | 2.149077e-5 |
GO:0045835 | negative regulation of meiosis | 2.363117e-5 |
GO:0002687 | positive regulation of leukocyte migration | 2.405641e-5 |
GO:0048265 | response to pain | 2.420875e-5 |
GO:0021513 | spinal cord dorsal/ventral patterning | 2.640771e-5 |
GO:0032069 | regulation of nuclease activity | 2.665339e-5 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 2.773310e-5 |
GO:0045176 | apical protein localization | 2.954878e-5 |
GO:0001710 | mesodermal cell fate commitment | 3.056214e-5 |
GO:0043271 | negative regulation of ion transport | 3.375318e-5 |
GO:0035050 | embryonic heart tube development | 3.582709e-5 |
GO:0030704 | vitelline membrane formation | 3.801485e-5 |
GO:0010459 | negative regulation of heart rate | 4.071390e-5 |
GO:0048665 | neuron fate specification | 4.372545e-5 |
GO:0071423 | malate transmembrane transport | 4.392772e-5 |
GO:0015709 | thiosulfate transport | 4.392772e-5 |
GO:0006401 | RNA catabolic process | 4.429411e-5 |
GO:0035456 | response to interferon-beta | 4.976433e-5 |
GO:0010759 | positive regulation of macrophage chemotaxis | 5.046866e-5 |
GO:0060215 | primitive hemopoiesis | 5.440109e-5 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 5.558345e-5 |
GO:0046330 | positive regulation of JNK cascade | 5.588291e-5 |
GO:0046697 | decidualization | 5.935015e-5 |
GO:0071622 | regulation of granulocyte chemotaxis | 6.318078e-5 |
GO:0002685 | regulation of leukocyte migration | 6.431170e-5 |
GO:0032472 | Golgi calcium ion transport | 6.548983e-5 |
GO:0030026 | cellular manganese ion homeostasis | 6.548983e-5 |
GO:0032468 | Golgi calcium ion homeostasis | 6.548983e-5 |
GO:0035803 | egg coat formation | 6.687251e-5 |
GO:0071636 | positive regulation of transforming growth factor beta production | 6.735817e-5 |
GO:0035690 | cellular response to drug | 6.764316e-5 |
GO:0010889 | regulation of sequestering of triglyceride | 6.839961e-5 |
GO:0061113 | pancreas morphogenesis | 7.043825e-5 |
GO:0010509 | polyamine homeostasis | 7.043825e-5 |
GO:0060816 | random inactivation of X chromosome | 7.043825e-5 |
GO:0090224 | regulation of spindle organization | 7.151913e-5 |
GO:0001661 | conditioned taste aversion | 7.161877e-5 |
GO:0060081 | membrane hyperpolarization | 7.677661e-5 |
GO:0035095 | behavioral response to nicotine | 8.030643e-5 |
GO:0006457 | protein folding | 8.513046e-5 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 9.106555e-5 |
GO:0003142 | cardiogenic plate morphogenesis | 9.106555e-5 |
GO:0021559 | trigeminal nerve development | 9.369521e-5 |
GO:0051926 | negative regulation of calcium ion transport | 9.613893e-5 |
GO:0033555 | multicellular organismal response to stress | 1.004432e-4 |
GO:0007009 | plasma membrane organization | 1.058462e-4 |
GO:0046320 | regulation of fatty acid oxidation | 1.127002e-4 |
GO:0072298 | regulation of metanephric glomerulus development | 1.147495e-4 |
GO:0072215 | regulation of metanephros development | 1.150093e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 1.159650e-4 |
GO:0048515 | spermatid differentiation | 1.162629e-4 |
GO:0007286 | spermatid development | 1.188601e-4 |
GO:0072659 | protein localization in plasma membrane | 1.218559e-4 |
GO:0021511 | spinal cord patterning | 1.242500e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 1.243842e-4 |
GO:0044238 | primary metabolic process | 1.260756e-4 |
GO:0021514 | ventral spinal cord interneuron differentiation | 1.305016e-4 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 1.320179e-4 |
GO:0007019 | microtubule depolymerization | 1.320179e-4 |
GO:0033687 | osteoblast proliferation | 1.415062e-4 |
GO:0071396 | cellular response to lipid | 1.465613e-4 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 1.571602e-4 |
GO:0090003 | regulation of establishment of protein localization in plasma membrane | 1.572039e-4 |
GO:0051385 | response to mineralocorticoid stimulus | 1.581110e-4 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.600330e-4 |
GO:0090234 | regulation of kinetochore assembly | 1.682491e-4 |
GO:0090169 | regulation of spindle assembly | 1.682491e-4 |
GO:0009106 | lipoate metabolic process | 1.717715e-4 |
GO:0061029 | eyelid development in camera-type eye | 1.740112e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 1.777825e-4 |
GO:0051412 | response to corticosterone stimulus | 1.783429e-4 |
GO:0045060 | negative thymic T cell selection | 1.788593e-4 |
GO:0009744 | response to sucrose stimulus | 1.821621e-4 |
GO:0043267 | negative regulation of potassium ion transport | 1.870272e-4 |
GO:0022403 | cell cycle phase | 1.880016e-4 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 1.890329e-4 |
GO:0032886 | regulation of microtubule-based process | 1.890541e-4 |
GO:0021506 | anterior neuropore closure | 1.915086e-4 |
GO:0045638 | negative regulation of myeloid cell differentiation | 1.922255e-4 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 1.923966e-4 |
GO:0030838 | positive regulation of actin filament polymerization | 1.944289e-4 |
GO:0060911 | cardiac cell fate commitment | 2.007251e-4 |
GO:0021603 | cranial nerve formation | 2.007251e-4 |
GO:0071469 | cellular response to alkalinity | 2.008501e-4 |
GO:0060623 | regulation of chromosome condensation | 2.008501e-4 |
GO:0071283 | cellular response to iron(III) ion | 2.008501e-4 |
GO:0046680 | response to DDT | 2.008501e-4 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 2.008501e-4 |
GO:0032273 | positive regulation of protein polymerization | 2.025453e-4 |
GO:0090004 | positive regulation of establishment of protein localization in plasma membrane | 2.103502e-4 |
GO:0034614 | cellular response to reactive oxygen species | 2.171257e-4 |
GO:0043383 | negative T cell selection | 2.181171e-4 |
GO:0044265 | cellular macromolecule catabolic process | 2.186213e-4 |
GO:0001970 | positive regulation of activation of membrane attack complex | 2.193142e-4 |
GO:0006984 | ER-nucleus signaling pathway | 2.206477e-4 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 2.262029e-4 |
GO:0006264 | mitochondrial DNA replication | 2.337234e-4 |
GO:0015827 | tryptophan transport | 2.337234e-4 |
GO:0044249 | cellular biosynthetic process | 2.343207e-4 |
GO:0060322 | head development | 2.344813e-4 |
GO:0060348 | bone development | 2.438435e-4 |
GO:0007530 | sex determination | 2.482895e-4 |
GO:0034599 | cellular response to oxidative stress | 2.495633e-4 |
GO:0046549 | retinal cone cell development | 2.505385e-4 |
GO:0014821 | phasic smooth muscle contraction | 2.526566e-4 |
GO:0001654 | eye development | 2.590403e-4 |
GO:0048075 | positive regulation of eye pigmentation | 2.627898e-4 |
GO:0061157 | mRNA destabilization | 2.653285e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 2.653285e-4 |
GO:0006346 | methylation-dependent chromatin silencing | 2.857013e-4 |
GO:0031346 | positive regulation of cell projection organization | 2.871516e-4 |
GO:0000921 | septin ring assembly | 2.936580e-4 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 2.958571e-4 |
GO:0021517 | ventral spinal cord development | 2.977687e-4 |
GO:0010039 | response to iron ion | 2.994694e-4 |
GO:0043010 | camera-type eye development | 3.016579e-4 |
GO:0015801 | aromatic amino acid transport | 3.071361e-4 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 3.075626e-4 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 3.253060e-4 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 3.260633e-4 |
GO:0030220 | platelet formation | 3.294738e-4 |
GO:0051645 | Golgi localization | 3.602022e-4 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 3.625901e-4 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 3.718879e-4 |
GO:0001708 | cell fate specification | 3.814133e-4 |
GO:0006939 | smooth muscle contraction | 3.834524e-4 |
GO:0009231 | riboflavin biosynthetic process | 3.885186e-4 |
GO:0060324 | face development | 3.925979e-4 |
GO:0030099 | myeloid cell differentiation | 3.934182e-4 |
GO:0051238 | sequestering of metal ion | 4.039239e-4 |
GO:0060026 | convergent extension | 4.046288e-4 |
GO:0007098 | centrosome cycle | 4.216584e-4 |
GO:0032075 | positive regulation of nuclease activity | 4.423482e-4 |
GO:0030218 | erythrocyte differentiation | 4.481897e-4 |
GO:0006208 | pyrimidine base catabolic process | 4.486459e-4 |
GO:0042461 | photoreceptor cell development | 4.580885e-4 |
GO:0048645 | organ formation | 4.643819e-4 |
GO:0072070 | loop of Henle development | 4.693916e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 4.695233e-4 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 4.707409e-4 |
GO:0051983 | regulation of chromosome segregation | 4.747818e-4 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 4.769633e-4 |
GO:2000615 | regulation of histone H3-K9 acetylation | 4.778220e-4 |
GO:0060279 | positive regulation of ovulation | 4.897560e-4 |
GO:0042541 | hemoglobin biosynthetic process | 4.916647e-4 |
GO:0032757 | positive regulation of interleukin-8 production | 4.916700e-4 |
GO:0051293 | establishment of spindle localization | 4.952357e-4 |
GO:0090129 | positive regulation of synapse maturation | 4.969523e-4 |
GO:0030224 | monocyte differentiation | 5.030106e-4 |
GO:0051984 | positive regulation of chromosome segregation | 5.032074e-4 |
GO:0048872 | homeostasis of number of cells | 5.079739e-4 |
GO:0006244 | pyrimidine nucleotide catabolic process | 5.143317e-4 |
GO:0021854 | hypothalamus development | 5.177487e-4 |
GO:0046113 | nucleobase catabolic process | 5.197146e-4 |
GO:0070172 | positive regulation of tooth mineralization | 5.305292e-4 |
GO:0045652 | regulation of megakaryocyte differentiation | 5.519427e-4 |
GO:0044087 | regulation of cellular component biogenesis | 5.554373e-4 |
GO:0003334 | keratinocyte development | 5.618978e-4 |
GO:0010824 | regulation of centrosome duplication | 5.641297e-4 |
GO:0006893 | Golgi to plasma membrane transport | 5.644837e-4 |
GO:0045765 | regulation of angiogenesis | 5.645751e-4 |
GO:0006355 | regulation of transcription, DNA-dependent | 5.685526e-4 |
GO:0006310 | DNA recombination | 5.724935e-4 |
GO:0032695 | negative regulation of interleukin-12 production | 5.980704e-4 |
GO:0035051 | cardiac cell differentiation | 6.084000e-4 |
GO:0060914 | heart formation | 6.085137e-4 |
GO:0043254 | regulation of protein complex assembly | 6.095068e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 6.111908e-4 |
GO:0035356 | cellular triglyceride homeostasis | 6.282273e-4 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 6.286279e-4 |
GO:0006824 | cobalt ion transport | 6.399185e-4 |
GO:0030194 | positive regulation of blood coagulation | 6.513688e-4 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 6.514105e-4 |
GO:0016331 | morphogenesis of embryonic epithelium | 6.520632e-4 |
GO:0046605 | regulation of centrosome cycle | 6.599948e-4 |
GO:0046599 | regulation of centriole replication | 6.737865e-4 |
GO:0042462 | eye photoreceptor cell development | 6.853132e-4 |
GO:0001841 | neural tube formation | 6.991029e-4 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 7.069184e-4 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 7.107528e-4 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 7.139240e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 7.228545e-4 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 7.336581e-4 |
GO:0072086 | specification of loop of Henle identity | 7.393850e-4 |
GO:0002577 | regulation of antigen processing and presentation | 7.478833e-4 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 7.483645e-4 |
GO:0033563 | dorsal/ventral axon guidance | 7.483645e-4 |
GO:0003407 | neural retina development | 7.495471e-4 |
GO:0006228 | UTP biosynthetic process | 7.502182e-4 |
GO:0006183 | GTP biosynthetic process | 7.502182e-4 |
GO:0006165 | nucleoside diphosphate phosphorylation | 7.502182e-4 |
GO:0022402 | cell cycle process | 7.542821e-4 |
GO:0002639 | positive regulation of immunoglobulin production | 7.569702e-4 |
GO:0060080 | regulation of inhibitory postsynaptic membrane potential | 7.590753e-4 |
GO:0042727 | flavin-containing compound biosynthetic process | 7.648061e-4 |
GO:0031119 | tRNA pseudouridine synthesis | 7.759168e-4 |
GO:0008616 | queuosine biosynthetic process | 7.759168e-4 |
GO:0001947 | heart looping | 7.770633e-4 |
GO:0030433 | ER-associated protein catabolic process | 7.836759e-4 |
GO:0097114 | N-methyl-D-aspartate receptor clustering | 7.853155e-4 |
GO:0097117 | guanylate kinase-associated protein clustering | 7.853155e-4 |
GO:0097112 | gamma-aminobutyric acid receptor clustering | 7.853155e-4 |
GO:0051208 | sequestering of calcium ion | 7.853155e-4 |
GO:0032677 | regulation of interleukin-8 production | 7.870461e-4 |
GO:0033762 | response to glucagon stimulus | 7.889311e-4 |
GO:0035967 | cellular response to topologically incorrect protein | 7.953553e-4 |
GO:0071397 | cellular response to cholesterol | 8.041455e-4 |
GO:0010722 | regulation of ferrochelatase activity | 8.138537e-4 |
GO:0001878 | response to yeast | 8.273090e-4 |
GO:0046836 | glycolipid transport | 8.425701e-4 |
GO:0035313 | wound healing, spreading of epidermal cells | 8.536688e-4 |
GO:0008105 | asymmetric protein localization | 8.536688e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 8.692423e-4 |
GO:0070584 | mitochondrion morphogenesis | 8.692423e-4 |
GO:0071398 | cellular response to fatty acid | 8.765824e-4 |
GO:0030827 | negative regulation of cGMP biosynthetic process | 9.112320e-4 |
GO:0060913 | cardiac cell fate determination | 9.117221e-4 |
GO:0090128 | regulation of synapse maturation | 9.164247e-4 |
GO:2000627 | positive regulation of miRNA catabolic process | 9.257778e-4 |
GO:0000964 | mitochondrial RNA 5'-end processing | 9.257778e-4 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 9.257778e-4 |
GO:0007017 | microtubule-based process | 9.613080e-4 |
GO:0052572 | response to host immune response | 9.725170e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 9.797143e-4 |
GO:0000042 | protein targeting to Golgi | 1.009554e-3 |
GO:0043652 | engulfment of apoptotic cell | 1.026363e-3 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 1.026363e-3 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.026363e-3 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 1.026363e-3 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 1.026363e-3 |
GO:0060708 | spongiotrophoblast differentiation | 1.034601e-3 |
GO:0048073 | regulation of eye pigmentation | 1.040200e-3 |
GO:0043241 | protein complex disassembly | 1.040266e-3 |
GO:0060038 | cardiac muscle cell proliferation | 1.044842e-3 |
GO:0048193 | Golgi vesicle transport | 1.079071e-3 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 1.135330e-3 |
GO:0071425 | hemopoietic stem cell proliferation | 1.135767e-3 |
GO:0031054 | pre-miRNA processing | 1.143737e-3 |
GO:0051661 | maintenance of centrosome location | 1.145394e-3 |
GO:0060349 | bone morphogenesis | 1.186818e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.237608e-3 |
GO:0023041 | neuronal signal transduction | 1.286559e-3 |
GO:0097105 | presynaptic membrane assembly | 1.286756e-3 |
GO:0000278 | mitotic cell cycle | 1.288427e-3 |
GO:0061077 | chaperone-mediated protein folding | 1.334545e-3 |
GO:0006879 | cellular iron ion homeostasis | 1.361771e-3 |
GO:0006958 | complement activation, classical pathway | 1.371306e-3 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.372683e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.373877e-3 |
GO:0046600 | negative regulation of centriole replication | 1.381024e-3 |
GO:0019061 | uncoating of virus | 1.449704e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 1.449704e-3 |
GO:0016095 | polyprenol catabolic process | 1.449704e-3 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 1.449704e-3 |
GO:0072600 | establishment of protein localization in Golgi | 1.464543e-3 |
GO:0006657 | CDP-choline pathway | 1.517713e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.549359e-3 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 1.581554e-3 |
GO:0048520 | positive regulation of behavior | 1.591027e-3 |
GO:0014020 | primary neural tube formation | 1.603106e-3 |
GO:0009132 | nucleoside diphosphate metabolic process | 1.616462e-3 |
GO:0006198 | cAMP catabolic process | 1.624204e-3 |
GO:0043148 | mitotic spindle stabilization | 1.630574e-3 |
GO:0002344 | B cell affinity maturation | 1.630574e-3 |
GO:0032722 | positive regulation of chemokine production | 1.651031e-3 |
GO:0046326 | positive regulation of glucose import | 1.653279e-3 |
GO:0051895 | negative regulation of focal adhesion assembly | 1.657302e-3 |
GO:0043525 | positive regulation of neuron apoptosis | 1.667905e-3 |
GO:0046888 | negative regulation of hormone secretion | 1.673016e-3 |
GO:0048246 | macrophage chemotaxis | 1.696389e-3 |
GO:0001974 | blood vessel remodeling | 1.706864e-3 |
GO:2000191 | regulation of fatty acid transport | 1.725714e-3 |
GO:0071422 | succinate transmembrane transport | 1.790534e-3 |
GO:0051130 | positive regulation of cellular component organization | 1.865276e-3 |
GO:0001843 | neural tube closure | 1.884551e-3 |
GO:0008045 | motor axon guidance | 1.920330e-3 |
GO:0043457 | regulation of cellular respiration | 1.977281e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 1.977281e-3 |
GO:0001886 | endothelial cell morphogenesis | 2.088771e-3 |
GO:0006241 | CTP biosynthetic process | 2.114014e-3 |
GO:0000041 | transition metal ion transport | 2.130199e-3 |
GO:0045665 | negative regulation of neuron differentiation | 2.150417e-3 |
GO:0050820 | positive regulation of coagulation | 2.154084e-3 |
GO:0020027 | hemoglobin metabolic process | 2.161139e-3 |
GO:0032891 | negative regulation of organic acid transport | 2.170684e-3 |
GO:0043624 | cellular protein complex disassembly | 2.231553e-3 |
GO:0050968 | detection of chemical stimulus involved in sensory perception of pain | 2.251140e-3 |
GO:0031023 | microtubule organizing center organization | 2.256016e-3 |
GO:0060017 | parathyroid gland development | 2.274585e-3 |
GO:0042726 | flavin-containing compound metabolic process | 2.296290e-3 |
GO:0030199 | collagen fibril organization | 2.326207e-3 |
GO:0016926 | protein desumoylation | 2.348807e-3 |
GO:0090085 | regulation of protein deubiquitination | 2.378569e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 2.378569e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 2.378569e-3 |
GO:0060606 | tube closure | 2.407473e-3 |
GO:0051297 | centrosome organization | 2.426289e-3 |
GO:0006119 | oxidative phosphorylation | 2.433089e-3 |
GO:0001958 | endochondral ossification | 2.444436e-3 |
GO:0034346 | positive regulation of type III interferon production | 2.472008e-3 |
GO:0046541 | saliva secretion | 2.472008e-3 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 2.474001e-3 |
GO:0030046 | parallel actin filament bundle assembly | 2.476256e-3 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 2.502066e-3 |
GO:0019217 | regulation of fatty acid metabolic process | 2.530013e-3 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 2.534941e-3 |
GO:0009058 | biosynthetic process | 2.537245e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 2.550090e-3 |
GO:0032642 | regulation of chemokine production | 2.568797e-3 |
GO:0070170 | regulation of tooth mineralization | 2.577758e-3 |
GO:0031326 | regulation of cellular biosynthetic process | 2.593940e-3 |
GO:0060337 | type I interferon-mediated signaling pathway | 2.668888e-3 |
GO:0070301 | cellular response to hydrogen peroxide | 2.668888e-3 |
GO:0034067 | protein localization in Golgi apparatus | 2.713632e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 2.813558e-3 |
GO:0071107 | response to parathyroid hormone stimulus | 2.917215e-3 |
GO:0009057 | macromolecule catabolic process | 2.918809e-3 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 2.922368e-3 |
GO:0009792 | embryo development ending in birth or egg hatching | 2.936778e-3 |
GO:0055017 | cardiac muscle tissue growth | 2.939602e-3 |
GO:0060042 | retina morphogenesis in camera-type eye | 3.004396e-3 |
GO:0001885 | endothelial cell development | 3.011015e-3 |
GO:0051799 | negative regulation of hair follicle development | 3.014205e-3 |
GO:0051964 | negative regulation of synapse assembly | 3.058589e-3 |
GO:0045073 | regulation of chemokine biosynthetic process | 3.098635e-3 |
GO:0034340 | response to type I interferon | 3.101569e-3 |
GO:0050803 | regulation of synapse structure and activity | 3.184562e-3 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 3.185494e-3 |
GO:0001771 | immunological synapse formation | 3.214527e-3 |
GO:0071482 | cellular response to light stimulus | 3.230529e-3 |
GO:0033211 | adiponectin-mediated signaling pathway | 3.265422e-3 |
GO:0051329 | interphase of mitotic cell cycle | 3.299726e-3 |
GO:0072376 | protein activation cascade | 3.340061e-3 |
GO:0090161 | Golgi ribbon formation | 3.364005e-3 |
GO:0090230 | regulation of centromere complex assembly | 3.364005e-3 |
GO:0045061 | thymic T cell selection | 3.375960e-3 |
GO:0010757 | negative regulation of plasminogen activation | 3.380426e-3 |
GO:0006051 | N-acetylmannosamine metabolic process | 3.433713e-3 |
GO:0071110 | histone biotinylation | 3.433713e-3 |
GO:0048592 | eye morphogenesis | 3.459539e-3 |
GO:0051445 | regulation of meiotic cell cycle | 3.479647e-3 |
GO:0051325 | interphase | 3.610110e-3 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 3.620467e-3 |
GO:0008057 | eye pigment granule organization | 3.620621e-3 |
GO:0051958 | methotrexate transport | 3.645353e-3 |
GO:0014740 | negative regulation of muscle hyperplasia | 3.645353e-3 |
GO:0045010 | actin nucleation | 3.645353e-3 |
GO:0071625 | vocalization behavior | 3.646149e-3 |
GO:0015884 | folic acid transport | 3.646149e-3 |
GO:0001819 | positive regulation of cytokine production | 3.665920e-3 |
GO:0051261 | protein depolymerization | 3.678346e-3 |
GO:0021521 | ventral spinal cord interneuron specification | 3.712868e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 3.769292e-3 |
GO:0050951 | sensory perception of temperature stimulus | 3.771316e-3 |
GO:0007281 | germ cell development | 3.804237e-3 |
GO:0030318 | melanocyte differentiation | 3.811947e-3 |
GO:0030206 | chondroitin sulfate biosynthetic process | 3.829419e-3 |
GO:0003306 | Wnt receptor signaling pathway involved in heart development | 3.859491e-3 |
GO:0000958 | mitochondrial mRNA catabolic process | 3.867497e-3 |
GO:0000965 | mitochondrial RNA 3'-end processing | 3.867497e-3 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 3.867497e-3 |
GO:0000962 | positive regulation of mitochondrial RNA catabolic process | 3.867497e-3 |
GO:0034101 | erythrocyte homeostasis | 3.937457e-3 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 4.000144e-3 |
GO:0060419 | heart growth | 4.013408e-3 |
GO:0006506 | GPI anchor biosynthetic process | 4.025140e-3 |
GO:0050873 | brown fat cell differentiation | 4.035105e-3 |
GO:0071850 | mitotic cell cycle arrest | 4.052256e-3 |
GO:0015942 | formate metabolic process | 4.121857e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 4.167888e-3 |
GO:0007163 | establishment or maintenance of cell polarity | 4.177880e-3 |
GO:0021515 | cell differentiation in spinal cord | 4.193786e-3 |
GO:0006501 | C-terminal protein lipidation | 4.199068e-3 |
GO:0019369 | arachidonic acid metabolic process | 4.210961e-3 |
GO:0032185 | septin cytoskeleton organization | 4.217040e-3 |
GO:0097091 | synaptic vesicle clustering | 4.230944e-3 |
GO:0014826 | vein smooth muscle contraction | 4.244906e-3 |
GO:0042921 | glucocorticoid receptor signaling pathway | 4.245726e-3 |
GO:0050955 | thermoception | 4.304001e-3 |
GO:0006882 | cellular zinc ion homeostasis | 4.317299e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 4.317299e-3 |
GO:0006259 | DNA metabolic process | 4.371490e-3 |
GO:0040020 | regulation of meiosis | 4.390513e-3 |
GO:0009889 | regulation of biosynthetic process | 4.437676e-3 |
GO:0061072 | iris morphogenesis | 4.438661e-3 |
GO:0071407 | cellular response to organic cyclic compound | 4.453311e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 4.462651e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 4.462651e-3 |
GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 4.479316e-3 |
GO:0030889 | negative regulation of B cell proliferation | 4.511446e-3 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 4.547010e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 4.558042e-3 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 4.562549e-3 |
GO:0070613 | regulation of protein processing | 4.584061e-3 |
GO:0002669 | positive regulation of T cell anergy | 4.622508e-3 |
GO:0002679 | respiratory burst involved in defense response | 4.625031e-3 |
GO:0048048 | embryonic eye morphogenesis | 4.642707e-3 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 4.654785e-3 |
GO:0001953 | negative regulation of cell-matrix adhesion | 4.681174e-3 |
GO:0034199 | activation of protein kinase A activity | 4.720730e-3 |
GO:0085029 | extracellular matrix assembly | 4.727535e-3 |
GO:0000236 | mitotic prometaphase | 4.752661e-3 |
GO:0031076 | embryonic camera-type eye development | 4.754753e-3 |
GO:0002675 | positive regulation of acute inflammatory response | 4.843560e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 4.886061e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 4.898965e-3 |
GO:0002457 | T cell antigen processing and presentation | 4.898965e-3 |
GO:0010477 | response to sulfur dioxide | 4.898965e-3 |
GO:0060562 | epithelial tube morphogenesis | 4.948683e-3 |
GO:2000106 | regulation of leukocyte apoptosis | 4.994466e-3 |
GO:0060078 | regulation of postsynaptic membrane potential | 4.994466e-3 |
GO:0008298 | intracellular mRNA localization | 5.042841e-3 |
GO:0032680 | regulation of tumor necrosis factor production | 5.050510e-3 |
GO:0046784 | intronless viral mRNA export from host nucleus | 5.085176e-3 |
GO:0043032 | positive regulation of macrophage activation | 5.098964e-3 |
GO:0002339 | B cell selection | 5.127148e-3 |
GO:0051647 | nucleus localization | 5.129550e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 5.165563e-3 |
GO:0002544 | chronic inflammatory response | 5.165563e-3 |
GO:0044319 | wound healing, spreading of cells | 5.202275e-3 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 5.202523e-3 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 5.202523e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090086 | negative regulation of protein deubiquitination | 2.182043e-12 |
GO:0090084 | negative regulation of inclusion body assembly | 2.214592e-10 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.375400e-9 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 2.539482e-9 |
GO:0090085 | regulation of protein deubiquitination | 3.104183e-9 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 3.521650e-8 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 4.509989e-8 |
GO:0034377 | plasma lipoprotein particle assembly | 1.170030e-7 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 1.400963e-7 |
GO:0010897 | negative regulation of triglyceride catabolic process | 1.400963e-7 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.029311e-7 |
GO:0034382 | chylomicron remnant clearance | 3.029311e-7 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 4.104984e-7 |
GO:0070842 | aggresome assembly | 4.903311e-7 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.011957e-6 |
GO:0090083 | regulation of inclusion body assembly | 1.377807e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.439584e-6 |
GO:0032488 | Cdc42 protein signal transduction | 1.476505e-6 |
GO:0060192 | negative regulation of lipase activity | 2.064506e-6 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.633198e-6 |
GO:0033205 | cell cycle cytokinesis | 2.950345e-6 |
GO:0016074 | snoRNA metabolic process | 3.026623e-6 |
GO:0060621 | negative regulation of cholesterol import | 3.036437e-6 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 3.237563e-6 |
GO:0003207 | cardiac chamber formation | 3.332051e-6 |
GO:0050707 | regulation of cytokine secretion | 3.547202e-6 |
GO:0032365 | intracellular lipid transport | 3.971354e-6 |
GO:0003211 | cardiac ventricle formation | 4.282286e-6 |
GO:0033373 | maintenance of protease location in mast cell secretory granule | 4.808156e-6 |
GO:0033382 | maintenance of granzyme B location in T cell secretory granule | 4.808156e-6 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 6.140789e-6 |
GO:0090336 | positive regulation of brown fat cell differentiation | 6.140789e-6 |
GO:0090271 | positive regulation of fibroblast growth factor production | 6.140789e-6 |
GO:0090082 | positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway | 6.140789e-6 |
GO:0090304 | nucleic acid metabolic process | 7.312657e-6 |
GO:0070368 | positive regulation of hepatocyte differentiation | 7.459333e-6 |
GO:0060620 | regulation of cholesterol import | 7.991368e-6 |
GO:0006730 | one-carbon metabolic process | 8.371087e-6 |
GO:0048143 | astrocyte activation | 8.622606e-6 |
GO:0050706 | regulation of interleukin-1 beta secretion | 1.152099e-5 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 1.411849e-5 |
GO:0035621 | ER to Golgi ceramide transport | 1.557971e-5 |
GO:0010758 | regulation of macrophage chemotaxis | 1.575654e-5 |
GO:0034380 | high-density lipoprotein particle assembly | 1.689561e-5 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 1.841281e-5 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 1.841281e-5 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 1.841281e-5 |
GO:0043414 | macromolecule methylation | 1.923484e-5 |
GO:0071248 | cellular response to metal ion | 2.073977e-5 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 2.221864e-5 |
GO:0032695 | negative regulation of interleukin-12 production | 2.254602e-5 |
GO:0001841 | neural tube formation | 2.651217e-5 |
GO:0050704 | regulation of interleukin-1 secretion | 2.755528e-5 |
GO:0032375 | negative regulation of cholesterol transport | 3.127383e-5 |
GO:0065005 | protein-lipid complex assembly | 3.625118e-5 |
GO:0001510 | RNA methylation | 3.668152e-5 |
GO:0031915 | positive regulation of synaptic plasticity | 4.149868e-5 |
GO:0007091 | mitotic metaphase/anaphase transition | 4.269031e-5 |
GO:0032259 | methylation | 4.789401e-5 |
GO:0090209 | negative regulation of triglyceride metabolic process | 4.897824e-5 |
GO:0051313 | attachment of spindle microtubules to chromosome | 5.002421e-5 |
GO:0014002 | astrocyte development | 5.400992e-5 |
GO:0001838 | embryonic epithelial tube formation | 5.594505e-5 |
GO:0033211 | adiponectin-mediated signaling pathway | 5.658268e-5 |
GO:0033363 | secretory granule organization | 5.859375e-5 |
GO:0070535 | histone H2A K63-linked ubiquitination | 5.916704e-5 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 5.916704e-5 |
GO:0050708 | regulation of protein secretion | 6.375533e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.454591e-5 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 6.668581e-5 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 7.587825e-5 |
GO:0071247 | cellular response to chromate | 7.587825e-5 |
GO:0032274 | gonadotropin secretion | 7.849259e-5 |
GO:0072175 | epithelial tube formation | 8.033128e-5 |
GO:0044029 | hypomethylation of CpG island | 8.496008e-5 |
GO:0051639 | actin filament network formation | 9.130908e-5 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 1.001504e-4 |
GO:0031247 | actin rod assembly | 1.010202e-4 |
GO:0000070 | mitotic sister chromatid segregation | 1.068137e-4 |
GO:0050711 | negative regulation of interleukin-1 secretion | 1.093794e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.154746e-4 |
GO:0009988 | cell-cell recognition | 1.169324e-4 |
GO:0032225 | regulation of synaptic transmission, dopaminergic | 1.212705e-4 |
GO:0006566 | threonine metabolic process | 1.228236e-4 |
GO:0002098 | tRNA wobble uridine modification | 1.228236e-4 |
GO:0035239 | tube morphogenesis | 1.294021e-4 |
GO:0032074 | negative regulation of nuclease activity | 1.371953e-4 |
GO:0030070 | insulin processing | 1.437579e-4 |
GO:0019371 | cyclooxygenase pathway | 1.437579e-4 |
GO:0070194 | synaptonemal complex disassembly | 1.442972e-4 |
GO:0042158 | lipoprotein biosynthetic process | 1.517143e-4 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.523421e-4 |
GO:0000819 | sister chromatid segregation | 1.524079e-4 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 1.566516e-4 |
GO:0010759 | positive regulation of macrophage chemotaxis | 1.678822e-4 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 1.690910e-4 |
GO:0003259 | cardioblast anterior-lateral migration | 1.690910e-4 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 1.690910e-4 |
GO:0003236 | sinus venosus morphogenesis | 1.690910e-4 |
GO:0003210 | cardiac atrium formation | 1.690910e-4 |
GO:0060920 | pacemaker cell differentiation | 1.833713e-4 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 1.988436e-4 |
GO:0060921 | sinoatrial node cell differentiation | 2.003508e-4 |
GO:0051235 | maintenance of location | 2.067475e-4 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 2.084648e-4 |
GO:0010467 | gene expression | 2.192496e-4 |
GO:0015696 | ammonium transport | 2.193332e-4 |
GO:0050710 | negative regulation of cytokine secretion | 2.324429e-4 |
GO:0003334 | keratinocyte development | 2.365428e-4 |
GO:0033364 | mast cell secretory granule organization | 2.393426e-4 |
GO:0032774 | RNA biosynthetic process | 2.458288e-4 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2.515617e-4 |
GO:0006807 | nitrogen compound metabolic process | 2.520776e-4 |
GO:0010468 | regulation of gene expression | 2.545605e-4 |
GO:0035148 | tube formation | 2.629824e-4 |
GO:0002009 | morphogenesis of an epithelium | 2.653015e-4 |
GO:0032008 | positive regulation of TOR signaling cascade | 2.679128e-4 |
GO:0006351 | transcription, DNA-dependent | 2.701319e-4 |
GO:0006438 | valyl-tRNA aminoacylation | 2.728376e-4 |
GO:0030046 | parallel actin filament bundle assembly | 2.763397e-4 |
GO:0010172 | embryonic body morphogenesis | 2.805746e-4 |
GO:0010595 | positive regulation of endothelial cell migration | 3.433709e-4 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 3.634981e-4 |
GO:0051481 | reduction of cytosolic calcium ion concentration | 3.634981e-4 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 3.758911e-4 |
GO:0019047 | provirus integration | 3.758911e-4 |
GO:0060563 | neuroepithelial cell differentiation | 3.963276e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 4.101174e-4 |
GO:0032369 | negative regulation of lipid transport | 4.196633e-4 |
GO:0060562 | epithelial tube morphogenesis | 4.199367e-4 |
GO:0034337 | RNA folding | 4.221526e-4 |
GO:0032486 | Rap protein signal transduction | 4.404059e-4 |
GO:0051252 | regulation of RNA metabolic process | 4.430380e-4 |
GO:0071281 | cellular response to iron ion | 4.464701e-4 |
GO:0000422 | mitochondrion degradation | 4.464701e-4 |
GO:0071675 | regulation of mononuclear cell migration | 4.542673e-4 |
GO:0090129 | positive regulation of synapse maturation | 4.752348e-4 |
GO:0003283 | atrial septum development | 4.933302e-4 |
GO:0034453 | microtubule anchoring | 5.025603e-4 |
GO:0070508 | cholesterol import | 5.062450e-4 |
GO:0090128 | regulation of synapse maturation | 5.244289e-4 |
GO:0048259 | regulation of receptor-mediated endocytosis | 5.296907e-4 |
GO:0043968 | histone H2A acetylation | 5.326809e-4 |
GO:0007080 | mitotic metaphase plate congression | 5.344430e-4 |
GO:0071241 | cellular response to inorganic substance | 5.424113e-4 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 5.448752e-4 |
GO:0017004 | cytochrome complex assembly | 5.588369e-4 |
GO:0042157 | lipoprotein metabolic process | 5.840174e-4 |
GO:0003161 | cardiac conduction system development | 5.845546e-4 |
GO:0007521 | muscle cell fate determination | 5.959467e-4 |
GO:0051276 | chromosome organization | 6.089279e-4 |
GO:0031326 | regulation of cellular biosynthetic process | 6.108286e-4 |
GO:0003163 | sinoatrial node development | 6.329801e-4 |
GO:0035752 | lysosomal lumen pH elevation | 6.338370e-4 |
GO:0001575 | globoside metabolic process | 6.338370e-4 |
GO:0000046 | autophagic vacuole fusion | 6.338370e-4 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 6.421509e-4 |
GO:0003166 | bundle of His development | 6.696087e-4 |
GO:0006642 | triglyceride mobilization | 7.057365e-4 |
GO:0048790 | maintenance of presynaptic active zone structure | 7.163123e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 7.173113e-4 |
GO:0045746 | negative regulation of Notch signaling pathway | 7.466441e-4 |
GO:0050995 | negative regulation of lipid catabolic process | 7.792999e-4 |
GO:0033700 | phospholipid efflux | 7.796724e-4 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 7.999228e-4 |
GO:0032849 | positive regulation of cellular pH reduction | 8.135676e-4 |
GO:0018243 | protein O-linked glycosylation via threonine | 8.212415e-4 |
GO:0018242 | protein O-linked glycosylation via serine | 8.212415e-4 |
GO:0009451 | RNA modification | 8.626716e-4 |
GO:0002318 | myeloid progenitor cell differentiation | 9.169451e-4 |
GO:0016070 | RNA metabolic process | 9.196281e-4 |
GO:0003357 | noradrenergic neuron differentiation | 9.239299e-4 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 9.378102e-4 |
GO:0015670 | carbon dioxide transport | 9.693819e-4 |
GO:0008033 | tRNA processing | 9.936726e-4 |
GO:0060255 | regulation of macromolecule metabolic process | 1.032012e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.045492e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 1.076392e-3 |
GO:0019240 | citrulline biosynthetic process | 1.092235e-3 |
GO:0044260 | cellular macromolecule metabolic process | 1.102165e-3 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 1.117734e-3 |
GO:0032069 | regulation of nuclease activity | 1.119816e-3 |
GO:0003230 | cardiac atrium development | 1.132835e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.148524e-3 |
GO:0001843 | neural tube closure | 1.205732e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.218093e-3 |
GO:0015724 | formate transport | 1.228660e-3 |
GO:0014057 | positive regulation of acetylcholine secretion | 1.228660e-3 |
GO:0034375 | high-density lipoprotein particle remodeling | 1.256364e-3 |
GO:0090270 | regulation of fibroblast growth factor production | 1.268746e-3 |
GO:0034227 | tRNA thio-modification | 1.268746e-3 |
GO:0032606 | type I interferon production | 1.280583e-3 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.280583e-3 |
GO:0030433 | ER-associated protein catabolic process | 1.316091e-3 |
GO:0051602 | response to electrical stimulus | 1.352070e-3 |
GO:0009889 | regulation of biosynthetic process | 1.423265e-3 |
GO:0014020 | primary neural tube formation | 1.426538e-3 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 1.426808e-3 |
GO:0061370 | testosterone biosynthetic process | 1.426808e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 1.426829e-3 |
GO:0019441 | tryptophan catabolic process to kynurenine | 1.459819e-3 |
GO:0006399 | tRNA metabolic process | 1.483388e-3 |
GO:0070541 | response to platinum ion | 1.490575e-3 |
GO:0001816 | cytokine production | 1.513955e-3 |
GO:0045185 | maintenance of protein location | 1.515985e-3 |
GO:0021915 | neural tube development | 1.558771e-3 |
GO:0034379 | very-low-density lipoprotein particle assembly | 1.586850e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.601289e-3 |
GO:0006334 | nucleosome assembly | 1.620557e-3 |
GO:0007264 | small GTPase mediated signal transduction | 1.664302e-3 |
GO:0033344 | cholesterol efflux | 1.683717e-3 |
GO:0050886 | endocrine process | 1.695786e-3 |
GO:0050709 | negative regulation of protein secretion | 1.721073e-3 |
GO:0071622 | regulation of granulocyte chemotaxis | 1.763149e-3 |
GO:0006325 | chromatin organization | 1.770270e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.786983e-3 |
GO:0002675 | positive regulation of acute inflammatory response | 1.795798e-3 |
GO:0071827 | plasma lipoprotein particle organization | 1.833504e-3 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 1.846611e-3 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.851415e-3 |
GO:0051588 | regulation of neurotransmitter transport | 1.882123e-3 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 1.892845e-3 |
GO:0035910 | ascending aorta morphogenesis | 1.892845e-3 |
GO:0032691 | negative regulation of interleukin-1 beta production | 1.903078e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 1.911056e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 1.911056e-3 |
GO:0046079 | dUMP catabolic process | 1.911056e-3 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 1.911056e-3 |
GO:0003409 | optic cup structural organization | 1.925926e-3 |
GO:0021623 | oculomotor nerve formation | 1.925926e-3 |
GO:0003404 | optic vesicle morphogenesis | 1.925926e-3 |
GO:0042664 | negative regulation of endodermal cell fate specification | 1.951568e-3 |
GO:0009088 | threonine biosynthetic process | 1.951568e-3 |
GO:0040040 | thermosensory behavior | 1.951568e-3 |
GO:0051659 | maintenance of mitochondrion location | 2.003202e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 2.014756e-3 |
GO:2000279 | negative regulation of DNA biosynthetic process | 2.020430e-3 |
GO:0030728 | ovulation | 2.035178e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 2.050308e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.053906e-3 |
GO:0060606 | tube closure | 2.106215e-3 |
GO:0035815 | positive regulation of renal sodium excretion | 2.150056e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.169366e-3 |
GO:0060986 | endocrine hormone secretion | 2.315183e-3 |
GO:0006561 | proline biosynthetic process | 2.323627e-3 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 2.323627e-3 |
GO:0071318 | cellular response to ATP | 2.340173e-3 |
GO:0016241 | regulation of macroautophagy | 2.340173e-3 |
GO:0014061 | regulation of norepinephrine secretion | 2.393642e-3 |
GO:0051171 | regulation of nitrogen compound metabolic process | 2.402915e-3 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 2.404213e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 2.495604e-3 |
GO:0051454 | intracellular pH elevation | 2.495604e-3 |
GO:0008582 | regulation of synaptic growth at neuromuscular junction | 2.495604e-3 |
GO:0035269 | protein O-linked mannosylation | 2.495604e-3 |
GO:0007126 | meiosis | 2.536092e-3 |
GO:0031175 | neuron projection development | 2.543664e-3 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 2.593188e-3 |
GO:0001542 | ovulation from ovarian follicle | 2.640640e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 2.654413e-3 |
GO:0001973 | adenosine receptor signaling pathway | 2.654413e-3 |
GO:0045672 | positive regulation of osteoclast differentiation | 2.672627e-3 |
GO:0003214 | cardiac left ventricle morphogenesis | 2.762964e-3 |
GO:0090381 | regulation of heart induction | 2.819764e-3 |
GO:0090361 | regulation of platelet-derived growth factor production | 2.819764e-3 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 2.861769e-3 |
GO:0070634 | transepithelial ammonium transport | 2.861769e-3 |
GO:0021965 | spinal cord ventral commissure morphogenesis | 2.905294e-3 |
GO:0040029 | regulation of gene expression, epigenetic | 2.910258e-3 |
GO:0006289 | nucleotide-excision repair | 2.919042e-3 |
GO:0001834 | trophectodermal cell proliferation | 2.923000e-3 |
GO:0000281 | cytokinesis after mitosis | 2.951051e-3 |
GO:0007339 | binding of sperm to zona pellucida | 2.986366e-3 |
GO:0016570 | histone modification | 2.996492e-3 |
GO:0032367 | intracellular cholesterol transport | 3.008641e-3 |
GO:0016331 | morphogenesis of embryonic epithelium | 3.016513e-3 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 3.161480e-3 |
GO:0007049 | cell cycle | 3.267515e-3 |
GO:0051657 | maintenance of organelle location | 3.331216e-3 |
GO:0045806 | negative regulation of endocytosis | 3.387752e-3 |
GO:0006414 | translational elongation | 3.387752e-3 |
GO:0046939 | nucleotide phosphorylation | 3.396643e-3 |
GO:0032692 | negative regulation of interleukin-1 production | 3.397443e-3 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 3.410836e-3 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 3.422732e-3 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 3.439618e-3 |
GO:0043691 | reverse cholesterol transport | 3.507515e-3 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 3.525626e-3 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 3.525626e-3 |
GO:0000236 | mitotic prometaphase | 3.525626e-3 |
GO:0050715 | positive regulation of cytokine secretion | 3.584529e-3 |
GO:0016568 | chromatin modification | 3.612057e-3 |
GO:0010430 | fatty acid omega-oxidation | 3.653022e-3 |
GO:0009159 | deoxyribonucleoside monophosphate catabolic process | 3.653022e-3 |
GO:0009438 | methylglyoxal metabolic process | 3.653022e-3 |
GO:0003289 | atrial septum primum morphogenesis | 3.732240e-3 |
GO:0010458 | exit from mitosis | 3.747559e-3 |
GO:0010594 | regulation of endothelial cell migration | 3.750373e-3 |
GO:0043170 | macromolecule metabolic process | 3.925582e-3 |
GO:0032227 | negative regulation of synaptic transmission, dopaminergic | 3.988559e-3 |
GO:0090303 | positive regulation of wound healing | 4.000957e-3 |
GO:0070172 | positive regulation of tooth mineralization | 4.000957e-3 |
GO:0006479 | protein methylation | 4.075302e-3 |
GO:0034446 | substrate adhesion-dependent cell spreading | 4.091380e-3 |
GO:0050714 | positive regulation of protein secretion | 4.127195e-3 |
GO:0022904 | respiratory electron transport chain | 4.157488e-3 |
GO:0043316 | cytotoxic T cell degranulation | 4.179441e-3 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 4.179441e-3 |
GO:0003241 | growth involved in heart morphogenesis | 4.179441e-3 |
GO:0051321 | meiotic cell cycle | 4.203346e-3 |
GO:0042178 | xenobiotic catabolic process | 4.301712e-3 |
GO:0009059 | macromolecule biosynthetic process | 4.314063e-3 |
GO:0051451 | myoblast migration | 4.385758e-3 |
GO:0014014 | negative regulation of gliogenesis | 4.415061e-3 |
GO:0014009 | glial cell proliferation | 4.450779e-3 |
GO:0010817 | regulation of hormone levels | 4.582533e-3 |
GO:0045351 | type I interferon biosynthetic process | 4.602621e-3 |
GO:0032651 | regulation of interleukin-1 beta production | 4.683799e-3 |
GO:0051954 | positive regulation of amine transport | 4.702394e-3 |
GO:0006259 | DNA metabolic process | 4.822314e-3 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 4.835424e-3 |
GO:0016569 | covalent chromatin modification | 4.842271e-3 |
GO:0003179 | heart valve morphogenesis | 4.859085e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 4.859085e-3 |
GO:0034728 | nucleosome organization | 5.114589e-3 |
GO:0018198 | peptidyl-cysteine modification | 5.146111e-3 |
GO:0006568 | tryptophan metabolic process | 5.146111e-3 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 5.305305e-3 |
GO:0050975 | sensory perception of touch | 5.305305e-3 |
GO:0071506 | cellular response to mycophenolic acid | 5.305305e-3 |
GO:0051129 | negative regulation of cellular component organization | 5.353022e-3 |
GO:0065004 | protein-DNA complex assembly | 5.410405e-3 |
GO:0018210 | peptidyl-threonine modification | 5.434188e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5.558104e-3 |
GO:0051651 | maintenance of location in cell | 5.571548e-3 |
GO:0009132 | nucleoside diphosphate metabolic process | 5.676187e-3 |
GO:0034201 | response to oleic acid | 5.688322e-3 |
GO:0070189 | kynurenine metabolic process | 5.688322e-3 |
GO:0035036 | sperm-egg recognition | 5.753500e-3 |
GO:0042360 | vitamin E metabolic process | 5.755265e-3 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 5.755265e-3 |
GO:0009589 | detection of UV | 5.755265e-3 |
GO:0034976 | response to endoplasmic reticulum stress | 6.047738e-3 |
GO:0006970 | response to osmotic stress | 6.080514e-3 |
GO:0045004 | DNA replication proofreading | 6.110870e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 6.110870e-3 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 6.110870e-3 |
GO:0045989 | positive regulation of striated muscle contraction | 6.149422e-3 |
GO:0071294 | cellular response to zinc ion | 6.151902e-3 |
GO:0035810 | positive regulation of urine volume | 6.151902e-3 |
GO:0048641 | regulation of skeletal muscle tissue development | 6.229721e-3 |
GO:0046709 | IDP catabolic process | 6.358320e-3 |
GO:0046032 | ADP catabolic process | 6.358320e-3 |
GO:0014745 | negative regulation of muscle adaptation | 6.358320e-3 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 6.358320e-3 |
GO:0003300 | cardiac muscle hypertrophy | 6.359124e-3 |
GO:2000297 | negative regulation of synapse maturation | 6.729645e-3 |
GO:0090174 | organelle membrane fusion | 6.729645e-3 |
GO:0001913 | T cell mediated cytotoxicity | 6.729645e-3 |
GO:0051586 | positive regulation of dopamine uptake | 6.729645e-3 |
GO:0003151 | outflow tract morphogenesis | 6.810962e-3 |
GO:0010574 | regulation of vascular endothelial growth factor production | 6.846210e-3 |
GO:0061303 | cornea development in camera-type eye | 6.850659e-3 |
GO:0003209 | cardiac atrium morphogenesis | 6.890636e-3 |
GO:0000726 | non-recombinational repair | 6.906975e-3 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 7.001945e-3 |
GO:0060413 | atrial septum morphogenesis | 7.042270e-3 |
GO:0030854 | positive regulation of granulocyte differentiation | 7.229037e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 7.397530e-3 |
GO:0032594 | protein transport within lipid bilayer | 7.441414e-3 |
GO:0070198 | protein localization to chromosome, telomeric region | 7.441414e-3 |
GO:0003170 | heart valve development | 7.447172e-3 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 7.470979e-3 |
GO:0002070 | epithelial cell maturation | 7.501436e-3 |
GO:0002673 | regulation of acute inflammatory response | 7.609525e-3 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 7.682247e-3 |
GO:0051155 | positive regulation of striated muscle cell differentiation | 7.728133e-3 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 7.808199e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 7.818431e-3 |
GO:0033522 | histone H2A ubiquitination | 7.949971e-3 |
GO:0003183 | mitral valve morphogenesis | 8.029071e-3 |
GO:0032652 | regulation of interleukin-1 production | 8.063333e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 8.169597e-3 |
GO:0072610 | interleukin-12 secretion | 8.289303e-3 |
GO:0097022 | lymphocyte migration into lymph node | 8.289303e-3 |
GO:0032206 | positive regulation of telomere maintenance | 8.289303e-3 |
GO:2000278 | regulation of DNA biosynthetic process | 8.298853e-3 |
GO:0015669 | gas transport | 8.362156e-3 |
GO:0071824 | protein-DNA complex subunit organization | 8.529266e-3 |
GO:0034470 | ncRNA processing | 8.613419e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 8.624472e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 8.624472e-3 |
GO:0007028 | cytoplasm organization | 8.624472e-3 |
GO:0007292 | female gamete generation | 8.707348e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 8.797016e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 8.821990e-3 |
GO:0002649 | regulation of tolerance induction to self antigen | 8.821990e-3 |
GO:0016242 | negative regulation of macroautophagy | 8.906232e-3 |
GO:0051310 | metaphase plate congression | 8.984405e-3 |
GO:0048167 | regulation of synaptic plasticity | 9.228805e-3 |
GO:0034381 | plasma lipoprotein particle clearance | 9.250728e-3 |
GO:0010873 | positive regulation of cholesterol esterification | 9.270766e-3 |
GO:0045992 | negative regulation of embryonic development | 9.347605e-3 |
GO:0022409 | positive regulation of cell-cell adhesion | 9.393579e-3 |
GO:0010955 | negative regulation of protein processing | 9.424508e-3 |
GO:0034660 | ncRNA metabolic process | 9.544480e-3 |
GO:0045933 | positive regulation of muscle contraction | 9.559569e-3 |
GO:0031323 | regulation of cellular metabolic process | 9.667949e-3 |
GO:0045109 | intermediate filament organization | 9.699029e-3 |
GO:0043065 | positive regulation of apoptosis | 9.709590e-3 |
GO:0048666 | neuron development | 9.782943e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 9.794696e-3 |
GO:0046785 | microtubule polymerization | 9.811930e-3 |
GO:0044030 | regulation of DNA methylation | 9.870492e-3 |
GO:0031622 | positive regulation of fever generation | 9.948298e-3 |
GO:0021954 | central nervous system neuron development | 9.987972e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 9.989203e-3 |
GO:0097026 | dendritic cell dendrite assembly | 1.008242e-2 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 1.008242e-2 |
GO:0021629 | olfactory nerve structural organization | 1.008242e-2 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 1.011883e-2 |
GO:0034502 | protein localization to chromosome | 1.011883e-2 |
GO:0003208 | cardiac ventricle morphogenesis | 1.015502e-2 |
GO:0035417 | negative regulation of mitotic prometaphase | 1.015828e-2 |
GO:0070254 | mucus secretion | 1.015828e-2 |
GO:0042376 | phylloquinone catabolic process | 1.015828e-2 |
GO:0033260 | DNA replication involved in S phase | 1.015828e-2 |
GO:0010266 | response to vitamin B1 | 1.015828e-2 |
GO:0035117 | embryonic arm morphogenesis | 1.017300e-2 |
GO:0010498 | proteasomal protein catabolic process | 1.034406e-2 |
GO:0009074 | aromatic amino acid family catabolic process | 1.040124e-2 |
GO:0035166 | post-embryonic hemopoiesis | 1.042148e-2 |
GO:0032006 | regulation of TOR signaling cascade | 1.042565e-2 |
GO:0060596 | mammary placode formation | 1.048046e-2 |
GO:0070170 | regulation of tooth mineralization | 1.064875e-2 |
GO:0002523 | leukocyte migration involved in inflammatory response | 1.113989e-2 |
GO:0072488 | ammonium transmembrane transport | 1.118411e-2 |
GO:0050873 | brown fat cell differentiation | 1.124957e-2 |
GO:0032456 | endocytic recycling | 1.145456e-2 |
GO:0034968 | histone lysine methylation | 1.161185e-2 |
GO:0031497 | chromatin assembly | 1.189759e-2 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 1.192548e-2 |
GO:0048814 | regulation of dendrite morphogenesis | 1.201883e-2 |
GO:0033563 | dorsal/ventral axon guidance | 1.211075e-2 |
GO:0070366 | regulation of hepatocyte differentiation | 1.211075e-2 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 1.212420e-2 |
GO:0001935 | endothelial cell proliferation | 1.235258e-2 |
GO:0002328 | pro-B cell differentiation | 1.238441e-2 |
GO:0070584 | mitochondrion morphogenesis | 1.245409e-2 |
GO:0006541 | glutamine metabolic process | 1.252850e-2 |
GO:0060155 | platelet dense granule organization | 1.268998e-2 |
GO:0045916 | negative regulation of complement activation | 1.268998e-2 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 1.270174e-2 |
GO:0043068 | positive regulation of programmed cell death | 1.287405e-2 |
GO:0032847 | regulation of cellular pH reduction | 1.300985e-2 |
GO:0015809 | arginine transport | 1.300985e-2 |
GO:0006400 | tRNA modification | 1.301102e-2 |
GO:0035082 | axoneme assembly | 1.308203e-2 |
GO:0046826 | negative regulation of protein export from nucleus | 1.337097e-2 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.338530e-2 |
GO:0080009 | mRNA methylation | 1.340708e-2 |
GO:2000612 | regulation of thyroid-stimulating hormone secretion | 1.340708e-2 |
GO:0070625 | zymogen granule exocytosis | 1.340708e-2 |
GO:0042264 | peptidyl-aspartic acid hydroxylation | 1.340708e-2 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 1.340708e-2 |
GO:0016598 | protein arginylation | 1.340708e-2 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.340708e-2 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1.346564e-2 |
GO:0060932 | His-Purkinje system cell differentiation | 1.387841e-2 |
GO:0060926 | pacemaker cell development | 1.387841e-2 |
GO:0070509 | calcium ion import | 1.392650e-2 |
GO:0007549 | dosage compensation | 1.392650e-2 |
GO:0022900 | electron transport chain | 1.395091e-2 |
GO:0051583 | dopamine uptake | 1.398352e-2 |
GO:0070988 | demethylation | 1.399542e-2 |
GO:0060696 | regulation of phospholipid catabolic process | 1.432633e-2 |
GO:0001771 | immunological synapse formation | 1.432633e-2 |
GO:0060011 | Sertoli cell proliferation | 1.433619e-2 |
GO:0021999 | neural plate anterior/posterior regionalization | 1.433619e-2 |
GO:0070498 | interleukin-1-mediated signaling pathway | 1.441634e-2 |
GO:0072321 | chaperone-mediated protein transport | 1.442893e-2 |
GO:0045590 | negative regulation of regulatory T cell differentiation | 1.442893e-2 |
GO:0030719 | P granule organization | 1.442893e-2 |
GO:0043201 | response to leucine | 1.442893e-2 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 1.442893e-2 |
GO:0044270 | cellular nitrogen compound catabolic process | 1.446097e-2 |
GO:0071236 | cellular response to antibiotic | 1.449336e-2 |
GO:0003139 | secondary heart field specification | 1.463298e-2 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.463298e-2 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 1.463298e-2 |
GO:0016265 | death | 1.466376e-2 |
GO:0040019 | positive regulation of embryonic development | 1.467741e-2 |
GO:0016577 | histone demethylation | 1.467741e-2 |
GO:0060900 | embryonic camera-type eye formation | 1.469348e-2 |
GO:0001893 | maternal placenta development | 1.502564e-2 |
GO:0042254 | ribosome biogenesis | 1.525526e-2 |
GO:0008219 | cell death | 1.527143e-2 |
GO:0046039 | GTP metabolic process | 1.537795e-2 |
GO:0009261 | ribonucleotide catabolic process | 1.547888e-2 |
GO:0060911 | cardiac cell fate commitment | 1.552261e-2 |